The present study demonstrated that the level of SYNJ2BP expression may be used as an indicator to distinguish between breast carcinomas and normal tissues, since it was found to correlate with breast carcinoma progression in breast tumor samples. The gene discussed is SYNJ2BP; the disease is breast neoplasm.